Riskpilot← Back to searchSign inGet full accessReformedica AB
ABActiveOrg 5566577887Ekorrst 10 FMedical specialists activities · NACE 8622Est. 20040 employees
Revenue 2024
SEK 0
EBITDA margin
—
+17% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
SEK -2K
+67% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -5K | +17% |
| Net profit | SEK -2K | +67% |
| Total assets | SEK 314K | -1% |
| Equity | SEK 313K | -1% |
| Employees | 0 | — |
Legal name
Reformedica AB
Org number
5566577887
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 mars 2004
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet består i att förvalta fast och lös egendom.
Address
Ekorrst 10 F
Phone
+4619185045
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −16 | −9 | −7 | −6 | −5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −16 | −9 | −7 | −6 | −5 |
| Net financials | — | — | — | — | 3 |
| Profit before tax | −16 | −9 | −7 | −6 | −2 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −16 | −9 | −7 | −6 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 347 | 328 | 322 | 317 | 314 |
| Equity | 337 | 328 | 321 | 315 | 313 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 0 | 1 | 1 | 1 |
| Total debt | 10 | — | 1 | 1 | 1 |
EBITDA margin
-500000.0%
This company
15.8%
Market median
-3164657% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20202024
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Reformedica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Erik Janson | Board of Directors | 0 companies |
| Ingrid Brita Enander Janson | Deputy Board Member | 0 companies |